Navigation Links
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Date:2/2/2011

o delivering innovative solutions that improve the care of people living with cancer.  Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches.  To learn more about Lilly's commitment to cancer, please visit www.LillyOncology.com.  

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations.  Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.

ALIMTA® (pemetrexed for injection), Lilly

GEMZAR® (gemcitabine HCl), Lilly

Indications and Important Safety Information for ALIMTA® (pemetrexed for injection)

ALIMTA is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

ALIMTA is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

ALIMTA is a treatment fo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
2. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
3. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
4. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
5. Top Bristol-Myers Squibb Executive Joins Patton Boggs
6. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
7. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
8. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
9. Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
10. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
11. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the ... of its common stock at a price to the ... Tandem from this offering are expected to be $56.3 ... estimated offering expenses payable by Tandem. All of the ...
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... Reportlinker.com announces that a new market research ... X-ray Equipment - Europe ... This package contains 28 X-ray equipment analyses ... Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, ...
... /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... China-based exporter and retailer of high-quality medical dressings and ... unaudited consolidated financial results for the fourth quarter ended ... quarter results are unaudited and subject to change. ...
Cached Medicine Technology:X-ray Equipment - Europe 2Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results 2Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results 3Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results 4Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results 5Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results 6
(Date:2/28/2015)... How would you describe your leadership ... all kinds of different leaders, each with their ... advantages and applications of different leadership styles, Ohio-based ... product this spring called The Leadership Report that ... personality type, leadership, and success. The Leadership Report ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Developers of ... of a new overlay plugin for Final Cut Pro X ... , “FCPX Overlay Chromatic gives users total control over 6k ... Austin, CEO of Pixel Film Studios. “FCPX Overlay Chromatic was ... easy to use interface.” , FCPX Overlay Chromatic Grunge 6K ...
(Date:2/28/2015)... 28, 2015 Memphis, TN: MedixSafe has ... for a new security reader named Guardian 2. ... is a new biometric scanner that significantly increases ... features, the new biometric scanner provides fast and ... , MedixSafe narcotics lockers with Vanguard ...
(Date:2/27/2015)... Hispanics develop alcoholic liver disease (ALD), a common ... earlier than Whites/Caucasians or African Americans, according to a ... previous research indicated that Hispanics tend to have more ... published online in the journal Alcoholism: Clinical and Experimental ... pinpoint racial and ethnic disparities in the ages at ...
(Date:2/27/2015)... Beverly Hills, CA (PRWEB) February 27, 2015 ... was in the air for those suffering from Sjögren’s ... had been discovered by researchers at the University of ... the next phase of research was to develop a ... to precisely detect the presence of new autoantibodies. Researchers ...
Breaking Medicine News(10 mins):Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2
... old-fashioned hard work, study says , , FRIDAY, Aug. ... exercise outcomes in people who have chronic obstructive ... , Creatine is a popular nutritional supplement used ... study included 100 COPD patients who received either ...
... of Diabetes and Digestive and Kidney Diseases (NIDDK) ... published several new resources to help people learn ... are among the most critical health problems in ... children and young adults. The publications address interstitial ...
... (Aug. 1, 2008) -- Quality of care varies greatly for ... of the country and category of health care facility, suggesting ... protocols, according to a new study that was published in ... Oncology (2008: Vol. 26, Issue 22). , The inconsistencies ...
... for completion of health risk assessment resulted in a 65% employee completion ... ... August 1, 2008 -- Employers are increasingly using incentives as the carrot ... issue brief from HealthFitness (OTC BB: HFIT) zeros in on the use ...
... consecutive year, Omega Institute will host an important conference at its ... disorders, to explore the latest research and development in treating and ... ... 1, 2008 -- For the second consecutive year, Omega Institute ...
... sleep apnea) is associated with an increased risk of ... Cohort, an 18-year observational study supported by the National ... Institutes of Health. Researchers found that adults (ages 30 ... the study were two to three times more likely ...
Cached Medicine News:Health News:Creatine Has Negligible Effect on COPD Exercise Rehab 2Health News:NIDDK publishes new resources about urologic and kidney disorders 2Health News:NIDDK publishes new resources about urologic and kidney disorders 3Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 3Health News:Omega to Hold Conference: Autism Through the Life Span II 2Health News:Omega to Hold Conference: Autism Through the Life Span II 3Health News:Sleep apnea linked to increased risk of death 2
... is a unique microprocessor controlled shaking incubator ... either 96 or 384 well format. Speed, ... control panel and all are displayed on ... the clear protective cover. The Millennium 2000 ...
... the only four-color, automated benchtop flow cytometry ... cell sorting. Designed specifically to support a ... offers software instrument control, auto-sample loading, and ... productivity. FACSCalibur is fully modular so it ...
... Ultracompact high end desktop multilaser flow ... any kind of cell analysis and absolute ... forward and two different side scatter signals ... channels. The new CyFlow ML instrument can ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
Medicine Products: